Your Immune System Has a Genetic Blueprint. Here's What It Says.

APOE is best known for its role in cholesterol transport and brain health, but it’s also a major controller of immune and inflammatory responses. This gene produces a protein that manages how your immune cells communicate, particularly in response to pathogens and stress. Your APOE variant determines how aggressively your immune system activates when it detects a threat, and how quickly it calms down afterward.

There are three main APOE variants: e2, e3, and e4. The e4 variant, carried by roughly 25-30% of the population, is associated with a more reactive immune response and higher baseline inflammation. This doesn’t mean your immune system is broken; it means your body tends to mount a faster, more aggressive initial response to threats. People with e4 often fight off infections quickly, but they’re also more prone to inflammatory flares and immune overreaction.

You might notice you catch colds quickly but recover just as fast. Or you experience stronger inflammatory responses to minor infections. You might struggle with autoimmune-type symptoms or have a history of stronger vaccine reactions. Your body is essentially set to a higher alert level, and knowing this allows you to support immune regulation rather than just immune stimulation.

MTHFR is the enzyme that converts dietary folate into the active form your cells can use. This sounds like a small job, but it’s foundational to immune function. Your immune system relies on one-carbon metabolism to build and repair DNA in immune cells, produce neurotransmitters that regulate immune response, and manage methylation reactions that control gene expression in T cells and B cells.

The C677T variant, carried by approximately 40% of people with European ancestry, reduces MTHFR enzyme efficiency by 40-70%. This means your cells struggle to process regular B vitamins into forms they can actually use. You could eat a diet rich in folate and still have functionally depleted methylation capacity. This shows up as impaired immune cell production, slower recovery from infections, and reduced ability to mount antibody responses to vaccines.

You might notice you catch colds that linger. You might have a history of infections that take longer to clear than they should. You might get vaccinated but have lower-than-expected antibody titers. You might feel like your immune system is running on fumes. This isn’t a character flaw; your B-vitamin conversion is literally working slower than the population average.

BRCA1 is famous for its role in cancer risk, but it does something equally important for your immune system: it manages DNA repair in dividing cells. Your immune cells divide rapidly to mount responses to threats, and they need efficient DNA repair to do this safely. BRCA1 also regulates inflammatory gene expression, controlling whether immune responses stay proportionate or escalate into chronic inflammation.

BRCA1 variants are less common than other genes on this list, but they’re significant when present. Roughly 1 in 300-400 people carry a BRCA1 mutation in European ancestry populations. Carriers often experience impaired DNA repair capacity in immune cells, slower immune recovery, and a tendency toward sustained inflammatory responses. Your immune system may take longer to resolve infections and be slower to return to baseline after immune activation. This can show up as lingering fatigue after illness, prolonged inflammatory markers, or difficulty with complete recovery.

You might notice infections that seem to drag on longer than expected. You might feel fatigued weeks after being sick. You might have a history of chronic inflammatory conditions. Your immune system isn’t weak; it’s slower at repair and reset, which requires different support strategies.

F5 produces Factor V, a clotting protein that does much more than prevent bleeding. It’s involved in inflammatory signaling between immune cells. The F5 Leiden variant, carried by roughly 5-7% of European ancestry populations, increases both clotting tendency and inflammatory activation. This gene affects how quickly your immune cells mobilize in response to threats and how efficiently they resolve inflammation afterward.

People with the F5 Leiden variant often have higher baseline inflammatory markers and experience stronger inflammatory responses. Your immune system may be set to a more reactive inflammatory state, and your body may take longer to fully resolve immune activation. This shows up as prolonged fatigue after infections, sustained inflammatory markers, or a tendency toward post-viral syndromes. It also means you’re more prone to clotting complications if you have other risk factors.

You might feel like your body stays in “fight mode” longer than it should. You might experience extended fatigue after getting sick. You might have a history of inflammation that’s slow to resolve. Your immune system is appropriately activated; the challenge is that the brake pedal is working slower than the accelerator.

CYP2D6 is a liver enzyme that metabolizes hundreds of compounds, including many that support immune function. It processes certain botanical ingredients, amino acids, and other compounds that help modulate immune response. Your CYP2D6 variant determines whether you metabolize these compounds quickly (rapid metabolizer), normally (intermediate), or slowly (poor metabolizer). This is critical because if you metabolize too quickly, immune-supporting compounds pass through your system without building up to therapeutic levels.

Roughly 5-10% of people of European ancestry are poor metabolizers of CYP2D6 substrates, and roughly 5-10% are ultra-rapid metabolizers. Poor metabolizers accumulate compounds in their system and need lower doses; ultra-rapid metabolizers burn through them quickly and need higher doses or more frequent dosing. Taking a standard dose of an immune-supporting supplement when you’re an ultra-rapid metabolizer means it’s cleared from your system before it can work. Conversely, poor metabolizers can experience side effects at doses others tolerate fine.

You might take supplements that don’t seem to have any effect. You might have tried herbal immune support and felt nothing. Or you might be sensitive to compounds that others tolerate easily. The problem isn’t that the supplement doesn’t work; it’s that your metabolism isn’t matching the dosing strategy.

HLA-DQ2 is part of the human leukocyte antigen system, which is your immune system’s pattern-recognition database. It determines which specific pathogens, allergens, and food proteins your immune cells can recognize and respond to. Think of HLA-DQ2 as the genetic template that tells your immune system which invaders to mount a strong response against and which ones to tolerate.

Roughly 30-40% of the global population carries HLA-DQ2. People with this variant have a particular immune profile: they mount strong responses to gluten proteins (which is why celiac disease is linked to HLA-DQ2) but may have different responses to common pathogens. They may also be more prone to cross-reactivity, where their immune system confuses different pathogens or food proteins for each other. HLA-DQ2 carriers often experience stronger reactions to specific triggers and may need more targeted immune avoidance strategies.

You might notice strong reactions to gluten even if you don’t have celiac disease. You might experience immune flares when exposed to certain foods or environmental triggers. You might have a history of food sensitivities or cross-reactivity patterns. Your immune system isn’t overactive; it’s tuned to recognize specific patterns, which means your immune support needs to be equally specific rather than general.